[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2003]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR5.100]

[Page 47]
 
                        TITLE 21--FOOD AND DRUGS
 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN 
                                SERVICES
 
PART 5--DELEGATIONS OF AUTHORITY AND ORGANIZATION--Table of Contents
 
           Subpart C--Human Drugs; Redelegations of Authority
 
Sec. 5.100  Issuance of notices implementing the provisions of the Drug Amendments of 1962.


    The Director, the Deputy Director, and the Directors, Office of 
Review Management and Office of Pharmaceutical Science, Center for Drug 
Evaluation and Research; and the Director, the Deputy Directors for 
Regulations and Policy and for Science, and the Director and Deputy 
Directors, Office of Device Evaluation, Center for Devices and 
Radiological Health, are authorized to issue notices and amendments 
thereto implementing section 107(c)(3) of the Drug Amendments of 1962 
(Pub. L. 87-781) by announcing new or revised efficacy findings on human 
drugs that are or were subject to the provisions of section 506 of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355). These officials 
may not further redelegate this authority.